Sarcoma

• 

  Subject Areas on Research

  • "Dedifferentiated" chordoma: a case report of the cytomorphologic findings on fine-needle aspiration. 
  • 1H MRI phase thermometry in vivo in canine brain, muscle, and tumor tissue. 
  • 3D numerical reconstruction of the hyperthermia induced temperature distribution in human sarcomas using DE-MRI measured tissue perfusion: validation against non-invasive MR temperature measurements. 
  • A Comparison of Late Mortality Among Survivors of Childhood Cancer in the United States and United Kingdom. 
  • A Fluorescence-Guided Laser Ablation System for Removal of Residual Cancer in a Mouse Model of Soft Tissue Sarcoma. 
  • A Novel Imaging System Distinguishes Neoplastic from Normal Tissue During Resection of Soft Tissue Sarcomas and Mast Cell Tumors in Dogs. 
  • A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma. 
  • A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal Therapy. 
  • A histopathologic study of 716 unselected eyes in patients with cancer at the time of death. 
  • A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer. 
  • A multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion. 
  • A novel imaging system permits real-time in vivo tumor bed assessment after resection of naturally occurring sarcomas in dogs. 
  • A phase I trial of hyperthermia-induced interleukin-12 gene therapy in spontaneously arising feline soft tissue sarcomas. 
  • A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma. 
  • A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results. 
  • A phase II trial testing the thermal dose parameter CEM43 degrees T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy. 
  • A quantitative microscopic approach to predict local recurrence based on in vivo intraoperative imaging of sarcoma tumor margins. 
  • Aberrant expression of cell-cycle regulatory proteins in human mesenchymal neoplasia. 
  • Accuracy of real time noninvasive temperature measurements using magnetic resonance thermal imaging in patients treated for high grade extremity soft tissue sarcomas. 
  • Acral myxoinflammatory fibroblastic sarcomas: MRI findings in four cases. 
  • Acute pancreatitis associated with administration of a nitric oxide synthase inhibitor in tumor-bearing dogs. 
  • Acute tissue injury activates satellite cells and promotes sarcoma formation via the HGF/c-MET signaling pathway. 
  • Adult testicular sarcoma: presentation, evaluation, and treatment. 
  • Advances in the Diagnosis and Management of Neonatal Sarcomas. 
  • Age-related disparities in the use of radiotherapy for treatment of localized soft tissue sarcoma. 
  • An Investigation of Cancer-Directed Surgery for Different Histologic Subtypes of Malignant Pleural Mesothelioma. 
  • An evolutionary framework for treating pediatric sarcomas. 
  • Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma. 
  • Anatomic tumor location influences the success of contemporary limb-sparing surgery and radiation among adults with soft tissue sarcomas of the extremities. 
  • Application of a panel of antiganglioside monoclonal antibodies to cytologic specimens. 
  • Assessment of multimodality therapy use for extremity sarcoma in the United States. 
  • Biphenotypic sarcoma with characteristics of both a Ewing sarcoma and a desmoplastic small round cell tumor. 
  • Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study. 
  • Bridging the translational gap: Implementation of multimodal small animal imaging strategies for tumor burden assessment in a co-clinical trial. 
  • CYP3A4/5 and pharmacogenetics in patients with sarcoma - Authors' reply. 
  • Changes in tumour oxygenation during fractionated hyperthermia and radiation therapy in spontaneous canine sarcomas. 
  • Characterization of a recombinant adenovirus vector encoding heat-inducible feline interleukin-12 for use in hyperthermia-induced gene-therapy. 
  • Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma. 
  • Chemotherapy in soft-tissue sarcoma: where do we go from here? 
  • Clinical and morphologic features of post-traumatic ocular sarcomas in cats. 
  • Clinical outcome after neoadjuvant thermoradiotherapy in high grade soft tissue sarcomas. 
  • Clinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with data from the Surveillance, Epidemiology, and End Results registry. 
  • Clinical outcomes of patients with advanced gastrointestinal stromal tumors: safety and efficacy in a worldwide treatment-use trial of sunitinib. 
  • Clinical, surgical, and molecular prognostic factors for survival after spinal sarcoma resection. 
  • Clonality of sarcomatous and carcinomatous elements in sarcomatoid carcinoma of the prostate. 
  • Coexistence of a chemotactic factor and a retroviral P15E-related chemotaxis inhibitor in human tumor cell culture supernatants. 
  • Combination testing of cediranib (AZD2171) against childhood cancer models by the pediatric preclinical testing program. 
  • Comparison of genomics and functional imaging from canine sarcomas treated with thermoradiotherapy predicts therapeutic response and identifies combination therapeutics. 
  • Complete heart block complicating retrograde left ventricular catheterization: case report and review. 
  • Comprehensive Surgical Treatment as the Mainstay of Management in Retroperitoneal Sarcomas: Retrospective Study from Two Non-sarcoma Specialist Centers. 
  • Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. 
  • Computed tomography of primary retroperitoneal malignancies. 
  • Computed tomography of virally induced canine brain tumors: a preliminary report. 
  • Concordance of histopathologic and cytologic grading in musculoskeletal sarcomas: can grades obtained from analysis of the fine-needle aspirates serve as the basis for therapeutic decisions? 
  • Considerations in fractionated proton radiation therapy: clinical potential and results. 
  • Contributions from surgeons to clinical trials and research on the management of soft tissue sarcoma. 
  • Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. 
  • Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma. 
  • Cryptococcal abscess imitating a soft-tissue sarcoma in an immunocompetent host: a case report. 
  • Cutaneous Metastasis of Alveolar Rhabdomyosarcoma in a Child. 
  • Cutaneous metastasis of SMARCA4-deficient thoracic sarcoma: A diagnostic dilemma with therapeutic implications. 
  • Defining a textbook surgical outcome for patients undergoing surgical resection of intermediate and high-grade soft tissue sarcomas of the extremities. 
  • Defining sarcoma specialist center: revisiting the volume effect. 
  • Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. 
  • Designing a Rational Follow-Up Schedule for Patients with Extremity Soft Tissue Sarcoma. 
  • Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA). 
  • Diagnosis of diffuse malignant mesothelioma: experience of a US/Canadian Mesothelioma Panel. 
  • Dietary methionine influences therapy in mouse cancer models and alters human metabolism. 
  • Different patterns of angiogenesis in sarcomas and carcinomas. 
  • Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial. 
  • Dual source hybrid spectral micro-CT using an energy-integrating and a photon-counting detector. 
  • Dual-Energy CT Imaging of Tumor Liposome Delivery After Gold Nanoparticle-Augmented Radiation Therapy. 
  • Dual-energy micro-computed tomography imaging of radiation-induced vascular changes in primary mouse sarcomas. 
  • Dynamic contrast-enhanced magnetic resonance imaging as a predictor of clinical outcome in canine spontaneous soft tissue sarcomas treated with thermoradiotherapy. 
  • E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms. 
  • E2F1-Mediated Induction of NFYB Attenuates Apoptosis via Joint Regulation of a Pro-Survival Transcriptional Program. 
  • Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor. 
  • Early follow-up of a custom non-fluted diaphyseal press-fit tumour prosthesis. 
  • Effect of calcitonin gene related peptide vs sodium nitroprusside to increase temperature in spontaneous canine tumours during local hyperthermia. 
  • Effect of chemotherapy on uptake of alkali metals by experimental tumors. 
  • Effect of glutamate analogues on brain tumor cell lines. 
  • Effect of low-dose prophylactic dopamine on high-dose cisplatin-induced electrolyte wasting, ototoxicity, and epidermal growth factor excretion: a randomized, placebo-controlled, double-blind trial. 
  • Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft-tissue sarcoma growth depend on tumor developmental stage. 
  • Emerging predictive biomarkers in the management of bone and soft tissue sarcomas. 
  • Emerging therapeutic targets for soft tissue sarcoma. 
  • Endoscopic ultrasound-guided fine-needle aspiration of intrathoracic and intra-abdominal spindle cell and mesenchymal lesions. 
  • Epidemiologic, functional, and oncologic outcome analysis of spinal sarcomas treated surgically at a single institution over 10 years. 
  • Epigenetic silencing of Kruppel like factor-3 increases expression of pro-metastatic miR-182. 
  • Epithelioid Hyalinizing Sarcoma With MGA-NUTM1 Fusion. 
  • Ex Vivo MR Histology and Cytometric Feature Mapping Connect Three-dimensional in Vivo MR Images to Two-dimensional Histopathologic Images of Murine Sarcomas. 
  • Examination of national lymph node evaluation practices for adult extremity soft tissue sarcoma. 
  • Extent of tumor fibrosis/hyalinization and infarction following neoadjuvant radiation therapy is associated with improved survival in patients with soft-tissue sarcoma. 
  • Extracellular pH and P-31 magnetic resonance spectroscopic variables are related to outcome in canine soft tissue sarcomas treated with thermoradiotherapy. 
  • Extremity soft tissue sarcomas presented as hematomas. 
  • Factors influencing the cell type of brain tumors induced in dogs by Schmidt-Ruppin Rous sarcoma virus. 
  • Failure patterns and survival in pediatric soft tissue sarcoma. 
  • Fasciitis ossificans with a radial neuropathy: a benign differential diagnosis for soft tissue sarcoma. 
  • Fine-needle aspiration cytology of articular and periarticular lesions. 
  • Fine-needle-aspiration cytology of a proximal type epithelioid sarcoma: A case report. 
  • Follicular dendritic cell sarcoma of the mediastinum. 
  • Frequent Mutations of POT1 Distinguish Pulmonary Sarcomatoid Carcinoma From Other Lung Cancer Histologies. 
  • Functional imaging of tumor vasculature using iodine and gadolinium-based nanoparticle contrast agents: a comparison of spectral micro-CT using energy integrating and photon counting detectors. 
  • Future directions in regional treatment strategies for melanoma and sarcoma. 
  • Glial-mesenchymal tropism of in vivo avian sarcoma virus neuro-oncogenesis in rats. 
  • HIF-1 Alpha Regulates the Response of Primary Sarcomas to Radiation Therapy through a Cell Autonomous Mechanism. 
  • High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support. A clinical and pharmacologic study. 
  • Hospital Volume Threshold for the Treatment of Retroperitoneal Sarcoma. 
  • Humeral Shaft Fracture With Placement of an Intramedullary Nail Through an Unrecognized Sarcoma. 
  • Hybrid spectral CT reconstruction. 
  • Hydropneumodissection-Assisted Cryoablation of Recurrent Sarcoma Adjacent to the Sciatic Nerve as a Limb-Sparing Alternative to Hindquarter Amputation. 
  • Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? 
  • INTRACRANIAL TUMORS IN INFANCY AND CHILDHOOD. A CLINICAL STUDY OF TWENTY CASES. 
  • Identification of CD146 as a marker enriched for tumor-propagating capacity reveals targetable pathways in primary human sarcoma. 
  • Identification of an immunoreactive glycoprotein in the urine of sarcoma patients. 
  • Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321. 
  • Imaging of human tumors and organs with N-13-labeled L-methionine. 
  • Immunobiology of primary intracranial tumors. 
  • Immunohistochemical detection of factor VIII/von Willebrand factor in hyperplastic endothelial cells in glioblastoma multiforme and mixed glioma-sarcoma. 
  • Impetiginous lesions in recurrent AML. 
  • Implications of Tumor Characteristics and Treatment Modality on Local Recurrence and Functional Outcomes in Children With Chest Wall Sarcoma: A Pediatric Surgical Oncology Research Collaborative Study. 
  • Improved hyperthermia treatment control using SAR/temperature simulation and PRFS magnetic resonance thermal imaging. 
  • In vivo characterization of tumor vasculature using iodine and gold nanoparticles and dual energy micro-CT. 
  • Individualizing systemic therapy for advanced soft tissue sarcomas based on tumor histology and biology. 
  • Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells. 
  • Influence of WR 2721 on radiation response of canine soft tissue sarcomas. 
  • Influence of age at inoculation on avian oncornavirus-induced brain tumor incidence, tumor morphology, and postinoculation survival in F344 rats. 
  • Initial testing of JNJ-26854165 (Serdemetan) by the pediatric preclinical testing program. 
  • Initial testing of cisplatin by the pediatric preclinical testing program. 
  • Initial testing of the investigational NEDD8-activating enzyme inhibitor MLN4924 by the pediatric preclinical testing program. 
  • Integrating carthage-specific T1rho MRI into knee clinic diagnostic imaging. 
  • Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis. 
  • Internal fixation of radiation-induced pathological fractures of the femur has a high rate of failure. 
  • Interobserver variation in the assessment of the sarcomatoid and transitional components in biphasic mesotheliomas. 
  • Intraoperative angiography imaging correlates with wound complications following soft tissue sarcoma resection. 
  • Intraoperative detection and removal of microscopic residual sarcoma using wide-field imaging. 
  • Intraoperative electron beam radiation therapy for retroperitoneal soft tissue sarcoma. 
  • Intraoperative radiation therapy. 
  • Intrinsic resistance to methotrexate in human soft tissue sarcoma cell lines. 
  • Investigating a chimeric anti-mouse PDGFRα antibody as a radiosensitizer in primary mouse sarcomas. 
  • Investigating readmission rates for patients undergoing oncologic resection and endoprosthetic reconstruction for primary sarcomas and tumors involving bone. 
  • Is there a role for sentinel lymph node biopsy in the management of sarcoma? 
  • Isolated Limb Infusion as a Limb Salvage Strategy for Locally Advanced Extremity Sarcoma. 
  • Limb preservation with isolated limb infusion for locally advanced nonmelanoma cutaneous and soft-tissue malignant neoplasms. 
  • Localization of tenascin in uterine sarcomas and partially transformed endometrial stromal cells. 
  • Logistic regression analysis of low grade spindle cell lesions. A cytologic study. 
  • Long-term Oncologic Outcomes After Neoadjuvant Radiation Therapy for Retroperitoneal Sarcomas. 
  • Loss of RB and MTS1/CDKN2 (p16) expression in human sarcomas. 
  • Low-grade fibromyxoid sarcoma of acral sites: Case report and literature review. 
  • Lysosomal accumulation of drugs in drug-sensitive MES-SA but not multidrug-resistant MES-SA/Dx5 uterine sarcoma cells. 
  • MR imaging and spectroscopy for prognostic evaluation in soft-tissue sarcomas. 
  • MRI-Based Deep Learning Segmentation and Radiomics of Sarcoma in Mice. 
  • Magnetic resonance thermometry during hyperthermia for human high-grade sarcoma. 
  • Making progress in a rare disease: emerging therapeutics in soft tissue sarcomas. 
  • Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review. 
  • Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation: do total dose, overall treatment time, and the surgery-radiotherapy interval impact on local control? 
  • Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG). 
  • Management of pelvic sarcoma. 
  • Mapping and characterization of the amplicon near APOA2 in 1q23 in human sarcomas by FISH and array CGH. 
  • Mesenchymal Tumors Can Derive from Ng2/Cspg4-Expressing Pericytes with β-Catenin Modulating the Neoplastic Phenotype. 
  • Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2. 
  • Methods to generate genetically engineered mouse models of soft tissue sarcoma. 
  • MicroRNA-16 suppresses metastasis in an orthotopic, but not autochthonous, mouse model of soft tissue sarcoma. 
  • MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes. 
  • Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity. 
  • Microsurgery in musculoskeletal oncology. 
  • Microvascular abnormalities in virally-induced canine brain tumors. Structural bases for altered blood-brain barrier function. 
  • Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET. 
  • Multidisciplinary Management of Oligometastatic Soft Tissue Sarcoma. 
  • Multidisciplinary approach to treatment of radiation-induced chest wall sarcoma. 
  • Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas. 
  • Mutational analysis of the PTEN gene in human uterine sarcomas. 
  • Mutational landscape in genetically engineered, carcinogen-induced, and radiation-induced mouse sarcoma. 
  • Myogenic transcription factors regulate pro-metastatic miR-182. 
  • Myoid differentiation and prognosis in adult pleomorphic sarcomas of the extremity: an analysis of 92 cases. 
  • NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021. 
  • NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021. 
  • NF1 deletion generates multiple subtypes of soft-tissue sarcoma that respond to MEK inhibition. 
  • Nanoparticle augmentation of radiotherapy in sarcoma. 
  • Neoadjuvant Radiation Therapy and Surgery Improves Metastasis-Free Survival over Surgery Alone in a Primary Mouse Model of Soft Tissue Sarcoma. 
  • Neurological disorders with abnormalities of immunoglobulin metabolism. 
  • Neutrophils promote tumor resistance to radiation therapy. 
  • Oncogene-dependent control of miRNA biogenesis and metastatic progression in a model of undifferentiated pleomorphic sarcoma. 
  • Ontogeny and oncogenesis balance the transcriptional profile of renal cell cancer. 
  • Opportunities for improving the therapeutic ratio for patients with sarcoma. 
  • Outcomes in a series of 103 retroperitoneal sarcomas. 
  • Overcoming a travel burden to high-volume centers for treatment of retroperitoneal sarcomas is associated with improved survival. 
  • Overcoming specialty bias: another important reason for multidisciplinary management of soft tissue sarcoma. 
  • PET/Computed Tomography and Precision Medicine: Musculoskeletal Sarcoma. 
  • Paleo-oncology: the role of ancient remains in the study of cancer. 
  • Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials. 
  • Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases. 
  • Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. 
  • Percutaneous pulmonary valve implantation in left pulmonary artery branch in a patient with a functional single lung. 
  • Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas. 
  • Pharmacokinetics & drug resistance of melphalan in regional chemotherapy: ILP versus ILI. 
  • Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors. 
  • Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1. 
  • Phase II study of docetaxel in advanced soft tissue sarcomas. 
  • Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial. 
  • Photon Counting CT and Radiomic Analysis Enables Differentiation of Tumors Based on Lymphocyte Burden. 
  • Physical activity among adult survivors of childhood lower-extremity sarcoma. 
  • Practical radiation oncology for extremity sarcomas. 
  • Preoperative hyperthermia and radiation for soft tissue sarcomas: advantage of two vs one hyperthermia treatments per week. 
  • Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. 
  • Pretreatment oxygenation profiles of human soft tissue sarcomas. 
  • Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables. 
  • Primary pediatric intraspinal sarcomas. Report of 3 cases. 
  • Primary sarcomas of the pancreas: A review of 253 patients from the National Cancer Data Base. 
  • Primary undifferentiated sarcoma of the thoracic aorta. 
  • Prostatic sarcoma with rapid tumor progression after nerve sparing radical cystoprostatectomy. 
  • Pulmonary carcinomas with a sarcomatoid element: an immunocytochemical and ultrastructural analysis. 
  • Quantitative scanning of soft-tissue sarcomas with nitrogen-13-labeled L-glutamate. 
  • Race is an independent predictor of survival in patients with soft tissue sarcoma of the extremities. 
  • Radiation Therapy for Soft Tissue Sarcoma: Indications and Controversies for Neoadjuvant Therapy, Adjuvant Therapy, Intraoperative Radiation Therapy, and Brachytherapy. 
  • Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomas. 
  • Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. 
  • Radiation therapy of sarcomas of the soft tissues. 
  • Radiation-Associated Sarcoma of the Head and Neck: Incidence, Latency, and Survival. 
  • Rapid growth of cutaneous metastases after surgical resection of thrombospondin-secreting small blue round cell tumor of childhood. 
  • Rationale and emerging strategies for immune checkpoint blockade in soft tissue sarcoma. 
  • Re: Kapp editorial IJROBP 35:189-194; 1996. 
  • Recent Insights into Notch Signaling in Embryonal Rhabdomyosarcoma. 
  • Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy. 
  • Relationships among tumor temperature, treatment time, and histopathological outcome using preoperative hyperthermia with radiation in soft tissue sarcomas. 
  • Renal carcinosarcoma. Ultrastructure and transplantation into athymic mice. 
  • Renal toxicity of ifosfamide in pilot regimens of the intergroup rhabdomyosarcoma study for patients with gross residual tumor. 
  • Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis. 
  • Response of canine soft tissue sarcomas to radiation or radiation plus hyperthermia: a randomized phase II study. 
  • Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy. 
  • Retroperitoneal sarcomas: does the center really matter? 
  • Sarcoma as the Prototype Disease for Adolescent and Young Adult Programs. 
  • Sarcoma of bone and soft tissue following treatment of Hodgkin's disease. 
  • Sarcoma treatment in the era of molecular medicine. 
  • Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis. 
  • Sarcomas in the elderly. 
  • Sarcomatoid Peritoneal Mesothelioma: Clinicopathologic Correlation of 13 Cases. 
  • Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases. 
  • Schwannoma of the kidney. 
  • Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. 
  • Simple and sensitive assay employing stable reagents for quantification of plasminogen activator. 
  • Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy. 
  • Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers? 
  • Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. 
  • Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. 
  • Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. 
  • Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines. 
  • Soft tissue sarcoma, version 2.2014. 
  • Soft tissue sarcoma. 
  • Soft tissue tumors of the prostate: a review. 
  • Soft-tissue sarcomas: detection of metabolic heterogeneity with P-31 MR spectroscopy. 
  • Spindle cell sarcoma of the vulva with myofibroblastic differentiation. 
  • Spindle cell stromal tumor of the pancreas: treatment by pancreatoduodenectomy. 
  • Structured Illumination Microscopy and a Quantitative Image Analysis for the Detection of Positive Margins in a Pre-Clinical Genetically Engineered Mouse Model of Sarcoma. 
  • Susceptibility of inbred Fischer rats to brain tumor induction by Rous sarcoma virus. 
  • Systematic review of charged-particle therapy for chordomas and sarcomas of the mobile spine and sacrum. 
  • Systemic therapy for advanced soft tissue sarcomas: highlighting novel therapies and treatment approaches. 
  • Targeted agents for sarcoma: is individualized therapy possible in such a diverse tumor type? 
  • Technological Advances, Biologic Rationales, and the Associated Success of Chemotherapy With Hyperthermia in Improved Outcomes in Patients With Sarcoma. 
  • Textbook Outcomes Among Patients Undergoing Retroperitoneal Sarcoma Resection. 
  • The Long Noncoding RNA NEAT1 Promotes Sarcoma Metastasis by Regulating RNA Splicing Pathways. 
  • The Role of Reconstructive Surgery After Skeletal and Soft Tissue Sarcoma Resection. 
  • The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining. 
  • The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center. 
  • The effect of neoadjuvant radiation therapy on perioperative outcomes among patients undergoing resection of retroperitoneal sarcomas. 
  • The effect of the setting of a positive surgical margin in soft tissue sarcoma. 
  • The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas. 
  • The fine structure of canine gliomas and intracranial sarcomas induced by the Schmidt-Ruppin strain of the Rous sarcoma virus. 
  • The histologic response of soft tissue sarcoma to radiation therapy. 
  • The p53 tumor suppressor gene frequently is altered in gynecologic cancers. 
  • The performance of a reduced-order adaptive controller when used in multi-antenna hyperthermia treatments with nonlinear temperature-dependent perfusion. 
  • The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy. 
  • The use of hydralazine to manipulate tumour temperatures during hyperthermia. 
  • Therapy monitoring in human and canine soft tissue sarcomas using magnetic resonance imaging and spectroscopy. 
  • Thermal dose fractionation affects tumour physiological response. 
  • Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy. 
  • Three-dimensional simulation of lung nodules for paediatric multidetector array CT. 
  • Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant. 
  • Total en bloc spondylectomy for locally aggressive and primary malignant tumors of the lumbar spine. 
  • Tracing Tumor Evolution in Sarcoma Reveals Clonal Origin of Advanced Metastasis. 
  • Treatment and outcomes of epithelioid sarcoma of the spine. 
  • Treatment of endometrial stromal tumors. 
  • Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle-based Chemotherapy in Pten-deleted Mouse Models of Sarcoma. 
  • Tumor cells, but not endothelial cells, mediate eradication of primary sarcomas by stereotactic body radiation therapy. 
  • Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. 
  • Tumor temperature distributions predict hyperthermia effect. 
  • Tumor-propagating side population cells are a dynamic subpopulation in undifferentiated pleomorphic sarcoma. 
  • Two patients with sarcoma. Case 2. Uterine sarcoma. 
  • Ultrastructural features of diffuse malignant mesotheliomas. 
  • Using units of CEM 43 degrees C T90, local hyperthermia thermal dose can be delivered as prescribed. 
  • Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas. 
  • Vascularized tissue transfer for closure of irradiated wounds after soft tissue sarcoma resection. 
  • What Are Risk Factors for and Outcomes of Late Amputation After Treatment for Lower Extremity Sarcoma: A Childhood Cancer Survivor Study Report. 
• 

  Keywords of People

  • Al-Rohil, Rami Nayef, Associate Professor of Pathology, Pathology
  • Badea, Cristian Tudorel, Professor in Radiology, Biomedical Engineering
  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Charles, Hal Cecil, Adjunct Associate Professor in the Department of Radiology, Radiology
  • Craciunescu, Oana, Professor of Radiation Oncology, Radiation Oncology
  • Deel, Michael D, Assistant Professor of Pediatrics, Pediatrics, Hematology-Oncology
  • Mosca, Paul Joseph, Associate Professor of Surgery, Surgical Oncology
  • Oristian, Kristi, Research Technician II, Pharmacology & Cancer Biology
  • Van Mater, David Sinclaire, Assistant Professor of Pediatrics, Pediatrics, Hematology-Oncology
  • Yoo, Sua, Associate Professor of Radiation Oncology, Radiation Oncology